RecallDepth
Class III Terminated

Azacitidine for Injection 100mg/vial Lyophilized Powder, Rx Only, Mfd. in Romania By: Sindan Pharma SRL For BluePoint Laboratories, NDC 68001-313-56

Company
Teva Pharmaceuticals Usa, Inc
Recall Initiated
July 22, 2022
Posted
August 17, 2022
Recall Number
D-1334-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
4162 cartons
Firm Location
Parsippany, NJ, United States

Reason for Recall

Subpotent Drug - Out of specification (OOS) result obtained during monitoring stability study for Assay. Results below specification.

Distribution

Distributed in Ohio

Lot / Code Info

Lot: FE22001A, Exp 01/2024

More recalls by Teva Pharmaceuticals Usa, Inc

View all recalls by this company →

Other recent Class III Drug recalls